BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Kalytera Announces Second U.S. Patent for Prevention and Treatment of Graft Versus Host Disease

  Kalytera’s Phase 2 study is expected to enroll 36 patients following allogeneic hematopoietic cell transplantation (“HCT”), commonly referred to as bone marrow transplantation.

  November 27, 2017

   · 

  5 min read
• Drug Development

  U.S. Label Update for Bioverativ’s ALPROLIX Adds Data Reinforcing Efficacy and Safety of Long-Term Prophylactic Treatment in Adults, Adolescents and Children With Hemophilia B

  These updates are based on interim data from the Phase 3 B-YOND open-label extension trial and final data from the Phase 3 Kids B-LONG pediatric study.

  November 27, 2017

   · 

  7 min read
• Policy

  Benitec Biopharma Provides Update on OPMD Orphan Disease Program

  In addition, over the past several weeks, the Benitec team has now completed pre-IND and scientific advice meetings with the U.S. FDA, Health Canada and several European agencies.

  November 27, 2017

   · 

  6 min read
• BioMidwest

  Sigmascreening Showcases Sensitive Sigma Paddle at RSNA

  Based on breast-size and tissue-stiffness the Sensitive Sigma Paddle calculates the pressure to achieve an optimal compression of 75mmHg and allows for a highly reproducible procedure.

  November 27, 2017

   · 

  3 min read
• Drug Development

  Eureka Announces FDA Allowance of Investigational New Drug Application for ET190L1-ARTEMIS™ T cell Therapy in Relapsed and Refractory CD19+ Non-Hodgkin Lymphoma

  In preclinical studies, ET190L1-ARTEMIS matched the cancer killing potency of current CAR-T therapies but with a dramatic reduction in the levels of inflammatory cytokines released

  November 27, 2017

   · 

  3 min read
• Business

  twoXAR Announces Formation of Business Advisory Board

  Industry veterans Judy Lewent, Jonathan MacQuitty, and Howie Rosen bring to twoXAR nearly 90 years of combined R&D and commercial experience in the biopharmaceutical sector.

  November 27, 2017

   · 

  3 min read
• Business

  Materialise and Siemens Healthineers syngo.via Partner to Bring 3D Printing to Hospitals Worldwide

  The partnership makes Materialise Mimics inPrint software, a dedicated solution for printing anatomical models in hospitals, available to radiologists through the Siemens Healthineers syngo.via open app platform.

  November 27, 2017

   · 

  4 min read
• 

  Business

  AstraZeneca Partners Up With Chinese Fund to Launch New Biopharma Company

  The deal aims to accelerate local development of innovative medicines for patients in China and builds on AstraZeneca’s strong presence in the country.

  November 27, 2017

   · 

  4 min read
• Biotech Beach

  Thermo Fisher Scientific’s Expanded Genome Editing Tool Kit Supports Every Step in Researchers’ Workflow

  The product suite meets the full spectrum of researchers’ genome editing needs - from basic solutions for CRISPR beginners to sophisticated tools for highly efficient and precise genome editing in even the most challenging cell types.

  November 27, 2017

   · 

  4 min read
• Pharm Country

  Sectra Offers Radiology an Easy Way to Improve Gadolinium Tracking

  Sectra is showcasing Sectra DoseTrack, including this functionality, during the RSNA global radiology show in Chicago.

  November 27, 2017

   · 

  2 min read